Clinical Trial

Testing of a New Rapid Antigen Test for Plague in Ituri, Democratic Republic of the Congo.

Study acronym: RAPID-IT
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study is being done to learn more about the disease in Ituri and to evaluate a new rapid test that may help doctors find the disease more quickly. This research includes characterisation of clinical presentations and pathology of plague, as well as identification of circumstances that may increase the risk of infection. Biological samples collected include blood, mouth swab, saliva, a bubo aspirate and a sputum sample (the latter only in case of plague in the lungs). These samples will be used to test the performance of the new rapid study test.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-09-08; most recent amendment 2026-03-24.
Trial Details
NCT Number NCT07174648
Lead Sponsor Institute of Tropical Medicine, Belgium
Collaborators: Institut Pasteur, Université Paris-Saclay, Centre de Recherche en Maladies Tropicales de L'Ituri (CRMT), Institut National pour la Recherche Biomedicale (INRB)
Conditions Plague, Bubonic; Plague, Skin, Plague, Pneumonic
Enrollment 300 participants
Start Date 2026-05-01
Primary Completion 2029-01-02 (estimated)
Study Completion 2029-01-02 (estimated)
Updated on ClinicalTrials.gov 2026-03-27